Hubert Pehamberger

Hubert Pehamberger

Vienna, Austria

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Dermatoscopy-30 years after the First Consensus Conference

Dermatoscopy-30 years after the First Consensus Conference

Journal: Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
Published: September 06, 2019

High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen's Disease of the Hand.

High-risk Mucosal Human Papillomavirus Infection in Squamous Cell Carcinoma and Bowen's Disease of the Hand.

Journal: Acta dermato-venereologica
Published: January 18, 2019

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives.

Ludwig Boltzmann Cluster Oncology (LBC ONC): first 10 years and future perspectives.

Journal: Wiener klinische Wochenschrift
Published: May 14, 2018

Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters.

Effect of intravenous immunoglobulin administration on erythrocyte and leucocyte parameters.

Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: July 26, 2017

Proteomic identification of a marker signature for MAPKi resistance in melanoma.

Proteomic identification of a marker signature for MAPKi resistance in melanoma.

Journal: The EMBO journal
Published: December 02, 2016

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.

Diagnosis and treatment of melanoma. European consensus-based interdisciplinary guideline - Update 2016.

Journal: European journal of cancer (Oxford, England : 1990)
Published: May 13, 2016

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial.

Adjuvant treatment with pegylated interferon α-2a versus low-dose interferon α-2a in patients with high-risk melanoma: a randomized phase III DeCOG trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 26, 2016

Human Determinants and the Role of Melanocortin-1 Receptor Variants in Melanoma Risk Independent of UV Radiation Exposure.

Human Determinants and the Role of Melanocortin-1 Receptor Variants in Melanoma Risk Independent of UV Radiation Exposure.

Journal: JAMA dermatology
Published: April 07, 2016

1st Science Days of the Austrian Society of Dermatology and Venereology (ÖGDV Forschungstage).

1st Science Days of the Austrian Society of Dermatology and Venereology (ÖGDV Forschungstage).

Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
Published: March 31, 2016

Infrared A radiation promotes survival of human melanocytes carrying ultraviolet radiation-induced DNA damage.

Infrared A radiation promotes survival of human melanocytes carrying ultraviolet radiation-induced DNA damage.

Journal: Experimental dermatology
Published: January 29, 2016

Characterization of patients at high risk of melanoma in Austria.

Characterization of patients at high risk of melanoma in Austria.

Journal: The British journal of dermatology
Published: January 14, 2016

Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.

Impact of oncogenic BRAF mutations and p16 expression on the growth rate of early melanomas and naevi in vivo.

Journal: The British journal of dermatology
Published: November 10, 2015
Showing 1-12 of 44

Last Updated: 09/26/2026